Home › Funds › Citigroup Inc › AMPH
Citigroup Inc position in AMPH
AMPHASTAR PHARMACEUTICALS IN · Health Care
Latest position (Q2 2026)55.78K sh
Reported value held$1.13M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 30.51K | $580.00K | New |
| Q4 2021 | 30.44K | $709.00K | Hold |
| Q1 2022 | 38.66K | $1.39M | Add |
| Q2 2022 | 31.34K | $1.09M | Reduce |
| Q3 2022 | 30.99K | $871.00K | Reduce |
| Q4 2022 | 31.75K | $889.55K | Add |
| Q1 2023 | 24.75K | $928.09K | Reduce |
| Q2 2023 | 37.75K | $2.17M | Add |
| Q3 2023 | 41.59K | $1.91M | Add |
| Q4 2023 | 30.94K | $1.91M | Reduce |
| Q1 2024 | 34.95K | $1.53M | Add |
| Q2 2024 | 34.99K | $1.40M | Hold |
| Q3 2024 | 57.81K | $2.81M | Add |
| Q4 2024 | 63.17K | $2.35M | Add |
| Q1 2025 | 77.74K | $2.25M | Add |
| Q2 2025 | 64.00K | $55.20K | Reduce |
| Q3 2025 | 19.82K | $528.07K | Reduce |
| Q4 2025 | 767.00K | $707.25K | Add |
| Q1 2026 | 35.90K | $703.36K | Reduce |
| Q2 2026 | 55.78K | $1.13M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding AMPH
- Vanguard Group 2.61M sh · $69.85M · Q4 2025
- Marshall Wace 1.07M sh · $21.52M · Q2 2026
- Geode Capital Management 969.84K sh · $19.58M · Q2 2026
- D. E. Shaw & Co 887.05K sh · $17.90M · Q2 2026
- Renaissance Technologies 525.10K sh · $10.60M · Q2 2026
- Goldman Sachs Group 505.36K sh · $10.20M · Q2 2026
- UBS Group AG 393.11K sh · $7.93M · Q2 2026
- Northern Trust Corp 370.99K sh · $7.49M · Q2 2026
- Charles Schwab Investment Management 310.18K sh · $6.26M · Q2 2026
- BlackRock Inc 6.83M sh · $6.19M · Q2 2026
- Royce & Associates 294.76K sh · $5.95M · Q2 2026
- Two Sigma Investments 248.12K sh · $5.01M · Q2 2026